ProVerum’s ProVee system could offer patients a safe and effective treatment without the need for highly invasive surgery.

I am 71 and began having urinary issues due to benign prostatic hyperplasia (BPH) many years ago. I took alpha blockers ...

ProVerum has raised $80 million in venture capital funding to complete the development of its minimally invasive, stent-like implant to relieve the urinary symptoms of an enlarged prostat | The Dublin ...

ProVerum announced today that it closed an $80 million Series B equity financing to support its benign prostatic hyperplasia ...

The Trent Rockets (TRT) are all set to host the Birmingham Phoenix (BPH) at the Trent Bridge for the Match No. 31 of the ...

The 2016-founded Trinity College Dublin spin-out is behind ProVee, a minimally invasive solution for treating benign ...

Steve Church is taking on The Long Run this September, committing to ride 500km to help raise awareness and funds for men ...

ProVerum Limited, the developer of the ProVee® System for BPH, a minimally invasive solution for treating benign prostatic hyperplasia (BPH), announced today the closing of an $80 million Series B ...

Profound Medical Corp.’s TULSA-PRO system can treat BPH-related symptoms with safe, minimally invasive procedures. Click here ...

Procept BioRobotics Corporation targets a $20B BPH market with innovative robotics. Explore growth potential, revenue trends, ...

The treatment of benign prostatic hyperplasia (BPH) that causes lower urinary tract symptoms has advanced enormously since the days when it was a simple choice between no treatment with ...